Yderligere klinisk erfaring I et internationalt, enkelt- arm, open- label klinisk fase 3b forsøg (ENHANCE) modtog 2378 voksne patienter med svær sepsis drotrcogin alfa (aktiveret).
Further Clinical Experience In a Phase 3b international, single-arm, open-label clinical trial (ENHANCE), 2378 adult patients with severe sepsis received drotrecogin alfa (activated).